Tablet Medications Utilize Dry Mold Fiber Technology for Pulp Molding Packaging

Tablet Medications Utilize Dry Mold Fiber Technology for Pulp Molding Packaging

Bayer, the international pharmaceutical giant, has joined forces with PA and PulPac to establish the Blister Pack Collective. Leveraging PulPac's dry mold fiber technology, Bayer is now manufacturing a novel pulp molding packaging for tablet medications.
Dry mold fiber technology boasts an 80% lower carbon footprint compared to plastic packaging production, requiring significantly less water. The new pulp molding packaging crafted using this technique not only matches plastic packaging in terms of functionality, design, and tablet quantity but also promises to reduce at least 100,000 tons of plastic pharmaceutical packaging annually.
The production of pulp molding packaging for tablet medications addresses the issues related to the use of PVC in over-the-counter medications, prescription drugs, nutritional products, and confectionery. This move accelerates the sustainable development of tablet medication packaging, uniting pharmaceutical, consumer health, and fast-moving consumer goods companies while minimizing the use of disposable plastics.
Sanna Fager, Chief Commercial Officer of PulPac, expressed her enthusiasm, saying, "We look forward to bringing dry mold fiber tablet packaging to life with leading brands like Bayer. This collaboration allows us to swiftly advance towards innovative fiber packaging solutions, on a large scale, replacing unnecessary single-use plastics."
Jesse DelGigante, Global Packaging Innovation Director at Bayer Consumer Health, affirmed their commitment, stating, "We pledge to transition 100% of our packaging to recyclable or renewable materials by 2030, investing €100 million to transform our product manufacturing and consumption."

Follow OtaraPack to get more sustainable molded pulp packaging solution:
https://www.instagram.com/otarapack
https://www.facebook.com/otarapack
https://www.pinterest.com/OtaraPack
Back to blog